Barriers and Facilitators to Oral PrEP Use Among Transgender Women in New York City

Transgender women may face a disparate risk for HIV/AIDS compared to other groups. In 2012, Truvada was approved for daily use as HIV pre-exposure prophylaxis (PrEP). However, there is a dearth of research about barriers and facilitators to PrEP in transgender women. This paper will shed light on tr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:AIDS Behav
Main Authors: Rael, Christine Tagliaferri, Martinez, Michelle, Giguere, Rebecca, Bockting, Walter, MacCrate, Caitlin, Mellman, Will, Valente, Pablo, Greene, George J., Sherman, Susan, Footer, Katherine H.A., D’Aquila, Richard T., Carballo-Diéguez, Alex
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6160363/
https://ncbi.nlm.nih.gov/pubmed/29589137
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10461-018-2102-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados